- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 498/10
Total number of patents in this class: 919
10-year publication summary
|
36
|
67
|
56
|
66
|
64
|
64
|
96
|
92
|
76
|
58
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3748 |
29 |
| Bristol-myers Squibb Company | 4898 |
26 |
| Amgen Inc. | 4074 |
26 |
| F. Hoffmann-La Roche AG | 7925 |
23 |
| Novartis AG | 10849 |
22 |
| Boehringer Ingelheim International GmbH | 4650 |
22 |
| Hoffmann-La Roche Inc. | 3418 |
21 |
| Janssen Pharmaceutica N.V. | 3392 |
21 |
| Merck Patent GmbH | 5831 |
19 |
| Vertex Pharmaceuticals Incorporated | 1597 |
19 |
| Arvinas Operations, Inc. | 229 |
16 |
| Pfizer Inc. | 3387 |
14 |
| Daiichi Sankyo Company, Limited | 1869 |
12 |
| Nxera Pharma UK Limited | 169 |
12 |
| AstraZeneca AB | 2909 |
11 |
| Takeda Pharmaceutical Company Limited | 2713 |
11 |
| Nurix Therapeutics, Inc. | 102 |
11 |
| BASF SE | 20933 |
10 |
| Genentech, Inc. | 3976 |
10 |
| Teijin Limited | 1245 |
10 |
| Other owners | 574 |